Log in to your Inderes Free account to see all free content on this page.
Glycorex Transplantation
1.40 SEK
+2.56 %
Less than 1K followers
GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Glycorex Transplantation
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.5 | 10.5 | 35.2 | 9.7 | 10.2 | 9.6 | 9.4 | 38.8 |
| EBITDA | -0.7 | 0.9 | -1.1 | -0.9 | 1.3 | 0.2 | -0.5 | 2.0 |
| EBIT | -3.0 | -2.1 | -10.4 | -1.5 | -1.0 | -2.1 | -2.7 | -7.3 |
| EBIT-% | -40.3 % | -19.5 % | -29.7 % | -15.4 % | -10.1 % | -22.1 % | -28.6 % | -18.9 % |
| Profit before taxes | -3.2 | -2.1 | -11.0 | -1.7 | -1.1 | -2.2 | -2.7 | -7.8 |
| Net income | -3.2 | -2.0 | -10.9 | -1.7 | -1.1 | -2.2 | -2.7 | -7.7 |
Login required
This content is only available for logged in users